The Centers for Medicare & Medicaid Services late today on how it will implement its August interim final rule that makes collecting and reporting COVID-19 data a condition of participation for hospitals that participate in Medicare. The guidance includes new reporting requirements for hospitals, as well as enforcement provisions. Highlights of the guidance include:

  • the reduction of mandatory supply-related data reports to once-per-week submissions;
  • a requirement that psychiatric and rehabilitation hospitals report data only once per week;
  • beginning on Nov. 1, Remdesivir- and staffing-related data will be optional; and
  • additional reporting requirements that begin Nov. 1 for certain data on influenza patients.

CMS also describes the enforcement process, which will include initial letters notifying non-compliant hospitals. The initial letters for non-compliance will start going out tomorrow and be followed by warning letters beginning three weeks after initial notifications.

Hospitals that remain noncompliant will then receive a letter letting them know they will be terminated from the Medicare program unless they come into compliance within 30 days.

Related News Articles

Headline
The Supreme Court April 29 ruled 7-2 in favor of the Department of Health and Human Services in a case that challenged how HHS applied Congress’ formula for…
Headline
A study published April 8 by the Public Library of Science’s Journal of Global Public Health found that driving while infected with COVID-19 raises the risk of…
Headline
The Coalition to Strengthen America’s Healthcare today launched a new television and digital advertisement as part of its Medicaid campaign. The ad highlights…
News
The Centers for Medicare & Medicaid Services April 7 released finalized payment rates for calendar year 2026 Medicare Advantage and Part D plans. Payments…
Headline
The AHA today urged the Medicare Payment Advisory Commission to take specific actions on physician fee schedule payments following recommendations the…
Headline
The Centers for Medicare & Medicaid Services April 4 finalized changes to the Medicare Advantage and prescription drug programs for contract year 2026. The…